arrow

From NeuroLex

Jump to: navigation, search
Category:1-120 Truncated Alpha-Synuclein Drosophila
Authors Magali Periquet  +, Tudor Fulga  +, Liisa Myllykangas  +, Michael G. Schlossmacher  +, and Mel B. Feany  +
CurationStatus uncurated  +
Definition This transgenic drosophila expresses a for This transgenic drosophila expresses a form of alpha-synuclein that is a C-terminally truncated fragment comprising amino acids 1-120. This form of alpha-synuclein has an enhanced ability to aggregate and thus enhanced neurotoxicity. This mutant is used in research to determine the role of alpha-synuclein aggregation in neurodegenerative diseases, such as Parkinsons. degenerative diseases, such as Parkinsons.
Figure 1-3 +
Id nlx_organ_090801  +
JournalNumber 12 +
JournalVolume 27 +
Label 1-120 Truncated Alpha-Synuclein Drosophila  +
Modification dateThis property is a special property in this wiki. 28 October 2009 01:05:57  +
ModifiedDate 28 October 2009  +
PMID 17376994  +
Pages 3338-3346
PublicationDate March 21 +, 2007 +
PublicationName The Journal of Neuroscience +
Title Aggregated Alpha-Synuclein Mediates Dopaminergic Neurotoxicity In Vivo  +
Categories Mutant Drosophila
hide properties that link here 
  No properties link to this page.
 

 

Enter the name of the page to start browsing from.

*Neurolex imports many terms from existing community ontologies, e.g., the Gene Ontology. We try to re-use the original identifier when possible and often import content from the original ontology. However, Neurolex is a dynamic site and any content beyond the identifier should not be presumed to reflect the content or views of the source ontology. Users should consult with the authoritative source for each ontology for current information.